Risk-of-Malignancy Index in preoperative evaluation of clinically restricted ovarian cancer

Sao Paulo Medical Journal

Volumn 120, Issue 3, 2002, Pages 72-76

  Campos Torres, José Carlos ^a,b   Mauricette Derchain, Sophie Françoise ^a   Faúndes, Aníbal ^a   Gontijo, Renata Clementino ^a   Martinez, Edson Zangiacomi ^a   De Ângelo Andrade, Liliana Aparecida Lucci ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

CA 125; Menopausal status; Ovarian cancer; Risk of malignancy; Ultrasound

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MENOPAUSE; MORTALITY; OVARY CANCER; PELVIS TUMOR; PREOPERATIVE EVALUATION; PROBABILITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

EID: 30144434983     PISSN: 15163180     EISSN: 15163180     Source Type: Journal    
DOI: 10.1590/s1516-31802002000300003     Document Type: Article

References (23)

1. Oriel KA, Hartenbach EM, Remington PL. Trends in United States ovarian cancer mortality, 1979-1995. Obstet Gynecol 1999;93:30-3.
2. Datasus. Available at the URL address: http://www.datasus.gov.br
3. Gillis CR, Hole DJ, Still RM, Davis J, Kaye SB. Medical audit. Cancer registration and survival in ovarian cancer. Lancet 1991;337:611-2.
4. Menon U, Talaat A, Rosenthal ANN, et al. Performance of ultrasound as a second-line test to serum CA 125 in ovarian cancer screening. BJOG 2000;107(2):155-9.
5. Menon U, Jacobs IJ. Recent developments in ovarian cancer screening. Curr Opin Obstet Gynecol 2000;12:39-42.
6. Manjunath AP, Pratapkumar, Sujatha K, Vani R. Comparison of three Risk-of-Malignancy Indices in evaluation of pelvic masses. Gynecol Oncol 2001;81:225-9.
7. Yuen PM, Yu KM, YIP SK, Lau WC, Rogers MS, Chang A. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol 1997;177:109-14.
8. Ulrich U, Paulus W, Schneider A, Keckstein J. Laparoscopic surgery for complex ovarian masses. J Am Assoc Gynecol Laparosc 2000;7:377-80.
9. Flynn MK, Niloff JM. Outpatient mini-laparotomy for ovarian cysts. J Reprod Med 1999;44:399-404.
10. Shepherd JH, Monaghan JM. Surgical management of ovarian cancer. Gynecol Oncol 1996;38:332-8.
11. Benedet JL, Bender H, Jones III, Ngan HYS, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynecol Obstet 2000;70:209-62.
12. Kusnetzoff D, Gnochi D, Damonte C, Sananes C. Differential diagnosis of pelvic masses usefulness of CA125, transvaginal sonography and echo-Doppler. Int J Gynecol Cancer 1998;8:315-21.
13. Kurjak A, Kupesic S, Anic T, Kosuta. Three-dimensional ultrasound and power Doppler improve the diagnosis of ovarian lesions. Gynecol Oncol 2000;76:28-32.
14. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk-of-malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynecol 1990;97:922-9.
15. Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Nustad K. Evaluation of a risk-of-malignancy index based on serum CA 125, ultrasound findings and menopausal status in the preoperative diagnosis pelvic masses. Br J Obstet Gynecol 1996;103:826-31.
16. Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Br J Obstet Gynecol 1999;93:448-52.
17. Morgante G, Marca AL, Ditto A, Leo VD. Comparison of two malignancy risk indices based on serum CA 125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynecol 1999;106:524-7.
18. Sassone AM, Tritsch T, Artner A, Westhoff C, Warren WB. Transvaginal sonography characterization of ovarian disease: evaluation of a newscoring system to predict ovarian malignancy. Obstet Gynecol 1991;78:70-6.
19. Depriest PD, Shenson D, Fired A, et al. A morphologic index based on sonographic findings in ovarian cancer. Gynecol Oncol 1993;51:7-11.
20. FIGO cancer committee. Staging announcement. Gynecol Oncol 1986;25:383.
21. Altman DG, Bland JM. Diagnostic tests 2: predictive values. BMJ 1994;309:102.
22. Fures R, Bukovic D, Hodek B, Klaric B, Herman R, Grubisic G. Preoperative tumor marker CA 125 levels in relation to epithelial ovarian cancer stage. Coll Antropol 1999;23:189-94.
23. Brun JL, Feyler A, Chene G, Saurel J, Brun G, Hocke C. Long term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 2000;78:21-7.